Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study

Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study

<p>Abstract</p> <p>Background</p> <p>Aggressive non-melanoma skin cancer (deeply infiltrating, recurrent, and morphea form lesions) are therapeutically challenging because they require considerable tissue loss and may demand radical disfiguring surgery. Interferons (IFN...

Full description

Bibliographic Details
Main Authors:	Lopez-Saura Pedro, Barcelona-Perez Silvia, Garcia-Vega Yanelda, Anasagasti-Angulo Lorenzo, Bello-Rivero Iraldo
Format:	Article
Language:	English
Published:	BMC 2009-07-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/9/262

Similar Items

Seguridad del HeberFERON( en pacientes con carcinoma basal palpebral
by: Irene Rojas Rondón, et al.
Published: (2021-03-01)

Respuesta clínica del tratamiento con HerberFERON( en pacientes con carcinoma basal palpebral
by: Irene Rojas Rondón, et al.
Published: (2021-03-01)

HeberFERON in the treatment of patients with basal cell carcinoma of the ear
by: Vladimir Sánchez Linares, et al.
Published: (2023-05-01)

A co-formulation of interferons alpha2b and gamma distinctively targets cell cycle in the glioblastoma-derived cell line U-87MG
by: Jamilet Miranda, et al.
Published: (2023-08-01)

Combinación de interferones en pacientes con tumores cerebrales de alto grado de malignidad sin opciones terapéuticas
by: María Margarita Ríos-Cabrera, et al.
Published: (2023-11-01)

Previous contraceptive treatment relates to grey matter volumes in the hippocampus and basal ganglia
by: Belinda Pletzer, et al.
Published: (2019-07-01)

Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG
by: Dania Vázquez-Blomquist, et al.
Published: (2022-12-01)

Interferones una opción terapéutica moderna en el tratamiento de los carcinomas basocelulares
by: Ernesto Pérez Leyva, et al.
Published: (2016-06-01)

Pegylated interferon-alpha-2a for the treatment of ocular surface squamous neoplasia
by: Murtuza Nuruddin, et al.
Published: (2022-01-01)

HeberFERON y calidad de vida en el carcinoma basocelular facial
by: Vladimir Sánchez Linares, et al.
Published: (2022-03-01)

Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections
by: Aleksandr Ianevski, et al.
Published: (2021-12-01)

Treatment outcome with interferon alpha 2b in ocular surface squamous neoplasia: Recommendation as primary treatment by peripheral ophthalmologists
by: Rachna Meel, et al.
Published: (2021-01-01)

Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma
by: Morris Cindy A, et al.
Published: (2005-02-01)

Interferon and interferon-stimulated genes in HBV treatment
by: Qirong Li, et al.
Published: (2022-12-01)

Mohs micrographic surgery as treatment option for non-basal cell or squamous cell carcinomas in the United States
by: Carolina Puyana, et al.
Published: (2020-08-01)

Treatment of multiple Bowen's disease with squamous cell and basal cell carcinomas with oral acitretin combined with excision
by: Yuan-Yuan Li, et al.
Published: (2014-09-01)

Intralesional interferon alpha-2b as a novel treatment for periocular squamous cell carcinoma in horses.
by: Brittany B Martabano, et al.
Published: (2024-01-01)

Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers
by: Marisa Boff Costa, et al.
Published: (2018-01-01)

Treatment with pegylated interferon alpha 2b and ribavirin in patients unresponsive to previous treatments with standard interferon as monotherapy or combined with ribavirin Tratamiento con PEG interferón alfa 2b y ribavirina en enfermos previamente tratados con interferón estándar en monoterapia o combinado con ribavirina
by: F. Carnicer, et al.
Published: (2005-05-01)

“Interferon magic” in ocular surface squamous neoplasia
by: Sinumol Sukumaran Thulaseedharan, et al.
Published: (2018-01-01)

Topical interferon alpha-2b for treatment of noninvasive ocular surface squamous neoplasia with 360° limbal involvement
by: Siamak Zarei-Ghanavati, et al.
Published: (2014-01-01)

Interferons in the treatment of myeloproliferative neoplasms
by: Pankit Vachhani, et al.
Published: (2024-02-01)

Surgery of basal cell carcinoma around the lacrimal canaliculus can be necessary after primary treatment with intralesional interferon alpha 2b
by: Huerva V, et al.
Published: (2008-01-01)

Interferon and ribavirin combination treatment synergistically inhibit HCV internal ribosome entry site mediated translation at the level of polyribosome formation.
by: Rajesh Panigrahi, et al.
Published: (2013-01-01)

Molecular mechanisms of basal cell and squamous cell carcinomas /
by: Reichrath, J. (Jorg), 1962-
Published: (2006)

Review of the Tumor Microenvironment in Basal and Squamous Cell Carcinoma
by: Elizabeth Chiang, et al.
Published: (2023-04-01)

Synergistic Phototherapy-Molecular Targeted Therapy Combined with Tumor Exosome Nanoparticles for Oral Squamous Cell Carcinoma Treatment
by: Ming Li, et al.
Published: (2023-12-01)

Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegaly.
by: Julia Szendroedi, et al.
Published: (2008-01-01)

Basal cell carcinoma - principles of treatment
by: Dimitrijević Milovan V., et al.
Published: (2023-01-01)

Efficacy and safety of triple therapy with recombinant interleukin-1β, recombinant interferon-α and ribavirin in patients with chronic hepatitis C, genotype 1 infection, the non-responders to previous treatment with interferon and ribavirin
by: Yu. V. Lobzin, et al.
Published: (2014-09-01)

Interferon-Based Biopharmaceuticals: Overview on the Production, Purification, and Formulation
by: Leonor S. Castro, et al.
Published: (2021-04-01)

Interferon beta treatment of multiple sclerosis.
by: Markovitz, D
Published: (1994)

INTERFERON TREATMENT OF INFANTS WITH INTRAUTERINE INFECTIONS
by: O. V. Shamsheva, et al.
Published: (2015-08-01)

Enhancement of interferon treatment for large basaliomas
by: A. V. Molochkov, et al.
Published: (2017-08-01)

Merkel cell carcinoma in collision with squamous cell carcinoma and basal cell carcinoma in a patient on ruxolitinib treatment for myeloproliferative neoplasm
by: Viviana Barrera-Penagos, MD, et al.
Published: (2024-03-01)

Medicare claims data reliably identify treatments for basal cell carcinoma and squamous cell carcinoma: a prospective cohort study
by: Bridie S. Thompson, et al.
Published: (2016-04-01)

Basal-squamous cell carcinoma collision tumour in the facial region
by: Georgia E. Hallett, et al.
Published: (2021-10-01)

Trichoepithelioma and basal cell carcinoma with squamous differentiation: Is it causal or coincidental?
by: Palak Agarwal, et al.
Published: (2015-01-01)

Expression of heparanase in basal cell carcinoma and squamous cell carcinoma
by: Maria Aparecida Silva Pinhal, et al.
Published: (2016-10-01)

Callibrachion and Datheosaurus, two historical and previously mistaken basal caseasaurian synapsids from Europe
by: Frederik Spindler, et al.
Published: (2016-08-01)